These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 9112337

  • 41. Monocyte function in IDDM patients and healthy individuals.
    Mølvig J, Pociot F, Baek L, Worsaae H, Dall Wogensen L, Christensen P, Staub-Nielsen L, Mandrup-Poulsen T, Manogue K, Nerup J.
    Scand J Immunol; 1990 Sep; 32(3):297-311. PubMed ID: 1698309
    [Abstract] [Full Text] [Related]

  • 42. Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis.
    Volarevic V, Al-Qahtani A, Arsenijevic N, Pajovic S, Lukic ML.
    Autoimmunity; 2010 Jun; 43(4):255-63. PubMed ID: 19845478
    [Abstract] [Full Text] [Related]

  • 43. Lipopolysaccharide from Actinobacillus actinomycetemcomitans stimulates production of interleukin-1beta, tumor necrosis factor-alpha, interleukin-6 and interleukin-1 receptor antagonist in human whole blood.
    Schytte Blix IJ, Helgeland K, Hvattum E, Lyberg T.
    J Periodontal Res; 1999 Jan; 34(1):34-40. PubMed ID: 10086884
    [Abstract] [Full Text] [Related]

  • 44. Circulating proinflammatory cytokines (IL-1 beta, TNF-alpha, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis.
    Sekiyama KD, Yoshiba M, Thomson AW.
    Clin Exp Immunol; 1994 Oct; 98(1):71-7. PubMed ID: 7923888
    [Abstract] [Full Text] [Related]

  • 45. Imbalances between tumor necrosis factor-alpha and its soluble receptor forms, and interleukin-1beta and interleukin-1 receptor antagonist in BAL fluid of cavitary pulmonary tuberculosis.
    Tsao TC, Hong Jh, Li LF, Hsieh MJ, Liao SK, Chang KS.
    Chest; 2000 Jan; 117(1):103-9. PubMed ID: 10631206
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Circulating interleukin-1 receptor antagonist concentrations are increased in adult patients with thermal injury.
    Mandrup-Poulsen T, Wogensen LD, Jensen M, Svensson P, Nilsson P, Emdal T, Mølvig J, Dinarello CA, Nerup J.
    Crit Care Med; 1995 Jan; 23(1):26-33. PubMed ID: 8001382
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Serum and in vitro production of IL-1 receptor antagonist correlate with C-reactive protein levels in newly diagnosed, untreated lupus patients.
    Liou LB.
    Clin Exp Rheumatol; 2001 Jan; 19(5):515-23. PubMed ID: 11579710
    [Abstract] [Full Text] [Related]

  • 50. Endurance run increases circulating IL-6 and IL-1ra but downregulates ex vivo TNF-alpha and IL-1 beta production.
    Drenth JP, Van Uum SH, Van Deuren M, Pesman GJ, Van der Ven-Jongekrijg J, Van der Meer JW.
    J Appl Physiol (1985); 1995 Nov; 79(5):1497-503. PubMed ID: 8594005
    [Abstract] [Full Text] [Related]

  • 51. Increased circulating cytokine receptors and ex vivo interleukin-1 receptor antagonist and interleukin-1beta production but decreased tumour necrosis factor-alpha production after a 5-km run.
    Drenth JP, Krebbers RJ, Bijzet J, van der Meer JW.
    Eur J Clin Invest; 1998 Oct; 28(10):866-72. PubMed ID: 9793002
    [Abstract] [Full Text] [Related]

  • 52. Interleukin-1-beta, tumor necrosis factor-alpha, insulin secretion and oral glucose tolerance in non-diabetic siblings of children with IDDM.
    el-Nawawy A, Soliman T, el-Azzouni O, Abbassy AA, Massoud MN, Marzouk S, Ibrahim F, Helal L.
    Indian J Pediatr; 1998 Oct; 65(3):455-60. PubMed ID: 10771998
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. The association of peripheral monocyte derived interleukin 1beta (IL-1beta), IL-1 receptor antagonist, and tumor necrosis factor-alpha with osteoarthritis in the elderly.
    Fraenkel L, Roubenoff R, LaValley M, McAlindon T, Chaisson C, Evans S, Harris T, Dinarello CA, Felson DT.
    J Rheumatol; 1998 Sep; 25(9):1820-6. PubMed ID: 9733466
    [Abstract] [Full Text] [Related]

  • 56. Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections.
    van Deuren M, van der Ven-Jongekrijg J, Demacker PN, Bartelink AK, van Dalen R, Sauerwein RW, Gallati H, Vannice JL, van der Meer JW.
    J Infect Dis; 1994 Jan; 169(1):157-61. PubMed ID: 8277177
    [Abstract] [Full Text] [Related]

  • 57. The dynamic responses of pro-inflammatory and anti-inflammatory cytokines of human mononuclear cells induced by uromodulin.
    Su SJ, Yeh TM.
    Life Sci; 1999 Jan; 65(24):2581-90. PubMed ID: 10619366
    [Abstract] [Full Text] [Related]

  • 58. Interleukin-1 receptor antagonist in neonates, children and adults, and in patients with pauci- and polyarticular onset juvenile chronic arthritis.
    Müller K, Zak M, Nielsen S, Pedersen FK, de Nully P, Bendtzen K.
    Clin Exp Rheumatol; 1997 Jan; 15(4):439-44. PubMed ID: 9272308
    [Abstract] [Full Text] [Related]

  • 59. Host-tumor interaction in ovarian cancer. Spontaneous release of tumor necrosis factor and interleukin-1 inhibitors by purified cell populations from human ovarian carcinoma in vitro.
    Burger RA, Grosen EA, Ioli GR, Van Eden ME, Brightbill HD, Gatanaga M, DiSaia PJ, Granger GA, Gatanaga T.
    Gynecol Oncol; 1994 Nov; 55(2):294-303. PubMed ID: 7959299
    [Abstract] [Full Text] [Related]

  • 60. Involvement of interleukin 1 and interleukin 1 antagonist in pancreatic beta-cell destruction in insulin-dependent diabetes mellitus.
    Mandrup-Poulsen T, Zumsteg U, Reimers J, Pociot F, Mørch L, Helqvist S, Dinarello CA, Nerup J.
    Cytokine; 1993 May; 5(3):185-91. PubMed ID: 8218929
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.